Brief: Bicycle Therapeutics Says Qtrly Net Loss Was $26.8 Million

Bicycle Therapeutics

04/08/2022 12:54

Aug 4 (Reuters) - Bicycle Therapeutics PLC  BCYC.O :
    * CASH AND CASH EQUIVALENTS OF $372.8 MILLION AS OF JUNE 30,
2022
    * EXPECTED FINANCIAL RUNWAY INTO 2025
    * NET LOSS WAS $26.8 MILLION, OR $0.90 BASIC AND DILUTED NET
LOSS
PER SHARE, FOR THREE MONTHS ENDED JUNE 30, 2022
    * Q2 EARNINGS PER SHARE VIEW $-0.85 -- REFINITIV IBES DATA

Source text for Eikon:  ID:nBw4RMrvMa 
Further company coverage:  BCYC.O 

 ((Reuters.Briefs@thomsonreuters.com;))